CAS: 2370013-12-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Sunvozertinib REF: IN-DA023P3QCAS: 2370013-12-8 | 98% | To inquire | Mon 02 Dec 24 |
 | Sunvozertinib REF: TM-T64124CAS: 2370013-12-8 | 98.11% - 99.71% | 36.00 €~1,375.00 € | Tue 21 Jan 25 |
Sunvozertinib
CAS:2370013-12-8
Formula:
C29H35ClFN7O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
584.0847
Ref: IN-DA023P3Q
| 1mg | 53.00 € | ||
| 5mg | 49.00 € | ||
| 10mg | 59.00 € | ||
| 25mg | 83.00 € | ||
| 50mg | 114.00 € | ||
| 100mg | 169.00 € | ||
| 250mg | 271.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Sunvozertinib
CAS:2370013-12-8
Sunvozertinib (DZD9008) is a potent ErbBs and BTK inhibitor, with inhibitory effects on EGFR, Her2.Cost-effective …
Formula:
C29H35ClFN7O3
Purity:
98.11% - 99.71%
Color and Shape:
Liquid
Molecular weight:
584.08
Ref: TM-T64124
| 1mg | 36.00 € | ||
| 5mg | 63.00 € | ||
| 10mg | 90.00 € | ||
| 25mg | 130.00 € | ||
| 50mg | 210.00 € | ||
| 100mg | 370.00 € | ||
| 500mg | 1,375.00 € | ||
| 1mL*10mM (DMSO) | 158.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
